LON:IBT International Biotechnology (IBT) Share Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free IBT Stock Alerts GBX 664 +6.00 (+0.91%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range 656.64▼ 67450-Day Range 604▼ 66452-Week Range 548▼ 704Volume63,742 shsAverage Volume60,852 shsMarket Capitalization£259.89 millionP/E Ratio632.38Dividend Yield4.22%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get International Biotechnology alerts: Email Address Ad Paradigm PressElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. About International Biotechnology Stock (LON:IBT)International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesJune 16 at 8:14 AM | americanbankingnews.comInternational Biotechnology (LON:IBT) Stock Price Passes Above 200-Day Moving Average of $639.91June 7, 2024 | americanbankingnews.comInternational Biotechnology (LON:IBT) Shares Pass Above Two Hundred Day Moving Average of $637.22April 13, 2024 | nytimes.comBiotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 TestApril 3, 2024 | uk.finance.yahoo.comFidelity Asian Values Plc - Directorate ChangeApril 3, 2024 | bizjournals.comBioConsortia raises $15 million to expand Davis lab, field trialsApril 2, 2024 | msn.comBharat Biotech, Bilthoven Biologicals join forces to fortify global polio eradication effortsMarch 26, 2024 | gurufocus.comInternational Biotechnology Trust PLC Introductory Video TranscriptMarch 25, 2024 | msn.comI'm a fund manager: Why biotech investor Ailsa Craig thinks rate cuts will spark a reboundMarch 9, 2024 | news.yahoo.comOur go-to guide for races in Livingston CountyFebruary 6, 2024 | investing.comInternational Biotechnology Trust plc (IBT)January 30, 2024 | marketwatch.comAvrobio to Merge With Tectonic Therapeutic in All-Stock DealJanuary 10, 2024 | benzinga.comComparing Biogen With Industry Competitors In Biotechnology IndustryJanuary 6, 2024 | reuters.comTrump meets Teamsters chief as union weighs presidential raceJanuary 4, 2024 | msn.comThis young biotech fund is worth a punt at a 25pc discountJanuary 3, 2024 | msn.comExclusive: Thermo Fisher halts DNA collection kit sales in TibetDecember 21, 2023 | businesswire.comImmunis Wins Two BASA Biotech Awards: “Best Small Business” and “Best Entrepreneur”December 17, 2023 | uk.finance.yahoo.comOzempic Maker’s Obesity-Fueled Gains Seen Slowing After Banner YearDecember 4, 2023 | tmcnet.comGlobal Bio-India 2023 attracts global interest for India's $300 billion biotech potential from companies, academia, and start-upsNovember 30, 2023 | msn.com4Moving Biotech shares innovative trial plans for GLP-1 osteoarthritis drugNovember 30, 2023 | markets.businessinsider.comCABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formulaNovember 29, 2023 | msn.comBharat Biotech Collaborates With University Of Sydney For Vaccine Research CollaborationSeptember 21, 2023 | msn.comBharat Biotech nears phase III trials for tuberculosis vaccineSeptember 13, 2023 | au.finance.yahoo.comInternational Biotechnology Ord (IBT.L)July 20, 2023 | wsj.comTCM Biotech International Corp.July 10, 2023 | uk.movies.yahoo.comHardman & Co Research on International Biotechnology Trust (IBT): Industry M&A remains a key driverSee More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CUSIPN/A CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 1.05 Trailing P/E Ratio632.38 Forward P/E Ratio747.76 P/E GrowthN/ANet Income£43.12 million Net Margins84.61% Pretax MarginN/A Return on Equity15.33% Return on Assets9.20% Debt Debt-to-Equity Ratio8.19 Current Ratio0.27 Quick Ratio0.32 Sales & Book Value Annual Sales£50.96 million Price / Sales5.10 Cash FlowGBX 4.26 per share Price / Cash Flow155.74 Book ValueGBX 725 per share Price / Book0.92Miscellaneous Outstanding Shares39,140,000Free FloatN/AMarket Cap£259.89 million OptionableNot Optionable Beta0.18 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMs. Catherine Elizabeth Bingham M.B.A. (Age 58)Managing Partner Claire JacksonCompany SecretaryDr. Carl Harald JansonLead Investment ManagerKey CompetitorsTR Property Investment TrustLON:TRYJPMorgan Elect plc - Managed GrowthLON:JPECapital GearingLON:CGTRuffer InvestmentLON:RICAFidelity Investment Trust - Fidelity Special ValuesLON:FSVView All CompetitorsInsidersCaroline GulliverBought 2,500 shares on 11/7/2023Total: £1.43 M ($573.00/share)Katherine Cornish-BowdenBought 1,500 shares on 8/3/2023Total: £949,500.00 ($633.00/share)View All Insider Transactions IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed in 2024? International Biotechnology's stock was trading at GBX 642 at the start of the year. Since then, IBT stock has increased by 3.4% and is now trading at GBX 664. View the best growth stocks for 2024 here. How often does International Biotechnology pay dividends? What is the dividend yield for International Biotechnology? International Biotechnology announced a dividend on Tuesday, December 12th. Investors of record on Thursday, December 21st will be given a dividend of GBX 13.90 per share on Friday, January 26th. This represents a dividend yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 21st. The official announcement can be viewed at this link. Read our dividend analysis for IBT. Is International Biotechnology a good dividend stock? International Biotechnology (LON:IBT) pays an annual dividend of GBX 28 per share and currently has a dividend yield of 5.18%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 2,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for IBT. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX). How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:IBT) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.